News Headline Summary

Novo Nordisk (NOVOB DC) shares open down 16% after it was reported that US regulators dealt a major blow to co.'s hopes for its new long acting insulin Tresiba by demanding they conduct annual clinical test to assess potential heart risks...

Update details:

- On the other hand, Sanofi Aventis shares up almost 4% as a result.

Print 08:02, 11 Feb 2013 - European Equities - Source: RANsquawk